Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Biostate AI

Explore full profile

Developing generative AI that can benefit human health by understanding and adapting to the dynamic nature of biological systems

Houston, United StatesFounded 2023Biotech & Life Sciences
Valuation $25–50M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Biostate AI and the history behind them.

About Biostate AI

Biostate AI, founded in 2023, is a biotechnology company that combines artificial intelligence with RNA sequencing to create generative AI models for predicting disease progression and drug response. The company aims to make molecular diagnostics more accessible and affordable, likening its approach to a "Netflix model" for this field.

Read full description

Biostate AI offers total RNA sequencing and free data analysis, partnering with academic researchers, hospital biorepositories, and pharmaceutical and biotech companies. This strategy allows them to leverage new technologies for scalable multiomic data generation. The company

Source: Dealroom company data

At a glance

Status
Operational
Founded
2023
Headquarters
Houston, United States
Employees
27
Open positions
None listed
Dealroom signal
62.2/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Genetics and genomics, Core AI, Biotech and Pharma, mRNA Medicines, Generative AI, genAI Applications
Technology
Artificial Intelligence, Machine Learning
Business model
SaaS
Client focus
b2b
Links
WebsiteLinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC May 2025 $12M $48M Gaingels · Vision Plus Capital · Catapult VC · Info Edge Ventures ↗
EARLY VC✓Equity / VC Jul 2024 $4M $16M Vision Plus Capital · Dario Amodei · Joris Poort · Michael Schnall-Levin ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Biostate AI website traffic

Latest recorded traffic for Biostate AI is 2.1K monthly website visits, down 44.7% over the last three months. Biostate AI's team declined 32.5% over the past year.

Latest monthly visits2.1K 3-month web change-44.7% 1-year team growth-32.5%
Monthly website visitsJul 2024–Jul 2026
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Proxima BioFormerly VantAI. Proximity therapeutics hijacking cellular machinery for protein degradation New York City, United States Operational 77 $80M $320M
RevrFormerly Tierra Biosciences. Accelerates bio-discovery using cell-free systems combined with powerful automation tools for data generation San Leandro, United States Operational
Deep GenomicsDeep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies Toronto, Canada Operational
Smart Medicines Original Medical TechnologyAn AI-driven macromolecular drug design service provider focused on using generative AI to develop innovative drug screening algorithms Minhang District, China Operational
VilyaDeveloping a novel class of drugs that precisely target the biology of disease Seattle, United States Operational
HelixNanoUses artificial intelligence to help cure genetic diseases Cambridge, United States Operational
AstromechStealth-mode AI startup engineering biologically grounded prompts for large models to aid genomic inference and synthetic biology Austin, United States Operational
Canary SpeechArtificial intelligence software for the healthcare industry to detect neurological diseases through voice analysis Provo, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A12 investors entered at this stage

  • Matter Venture Partners
  • Vision Plus Capital
  • Dario Amodei
  • Joris Poort
  • Michael Schnall-Levin
  • Caltech Seed Fund
  • Catapult VC
  • Emily Leproust
  • Accel
  • Gaingels
  • Info Edge Ventures
  • Mana Ventures

Other known investors1 additional known investor

  • Sahin Boydas

Talent

Book a demo to see the people
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States88.9%
🇮🇳 India11.1%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Biostate AI on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Biostate AI’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.